
Your Advantages
Biovac A 0.5ml Vaccine 0.5ml Injection
₹1,232
₹2,210
44% Off
Exclusive of 5% GST
Pack Size
Variant unavailable, Please select another variant
Similar Products
Delivery By
Enter location
Subtotal :
₹1,232
Want to buy bulk quantity?
Share your thoughts on this product
Incorrect Prices? Missing Information? Delivery time too high?
Brand Wockhardt
Biovac A 0.5ml Vaccine is a live attenuated vaccine indicated for active immunization against Hepatitis A, a contagious liver infection caused by the hepatitis A virus (HAV). It is formulated from the H2 attenuated strain of the Hepatitis A virus, propagated in human diploid cells, to stimulate the body's immune system to produce protective antibodies.
This vaccine is suitable for adults and children aged 1 year and older seeking protection against Hepatitis A. It is administered as a single 0.5ml dose via subcutaneous injection, typically over the deltoid muscle of the upper arm.
Biovac A 0.5ml Vaccine requires cold-chain storage, maintaining a temperature between +2°C and +8°C, protected from light, and must not be frozen. The vaccine is supplied as a freeze-dried powder and requires reconstitution with 0.5ml sterile water for injection, which is provided with the vial, and should be used within 1 hour after reconstitution.
Key Features :
Contains live attenuated Hepatitis A virus (H2 strain) for active immunization
Approved for use in adults and children aged 1 year and older
Requires cold-chain storage at +2°C to +8°C, protected from light, and must not be frozen
Administered via subcutaneous injection, typically in the deltoid muscle
A single 0.5ml dose is typically sufficient, with a booster dose usually not required
Requires reconstitution with 0.5ml sterile water for injection and should be used within 1 hour of reconstitution
Regulatory approval in India (implied by CDSCO documentation)
Overview of Biovac A Vaccine (0.5ml Injection)
Biovac A vaccine is a hepatitis A injection administered as a 0.5ml injection to provide protection against hepatitis A virus infection. It is recommended for children and adults at risk of exposure to hepatitis A, including travellers to endemic areas, healthcare workers, and individuals with chronic liver disease. The vaccine works by stimulating the immune system to produce antibodies, offering long-lasting immunity and helping prevent hepatitis A-related liver infections. Biovac A is typically given in a two-dose schedule, with the second dose administered 6–18 months after the first to ensure optimal protection.
Biovac A Vaccine Uses and Indications in Healthcare
Biovac A Vaccine uses is primarily to prevent hepatitis A infection in...